19 results
8-K
EX-99.1
XLO
Xilio Therapeutics Inc
5 Sep 23
Xilio Therapeutics Announces Promotion of Katarina Luptakova, M.D., to Chief Medical Officer and Scott Coleman, Ph.D., to Chief Development Officer
8:35am
to build upon our strong scientific foundation and continue our rapid pace of innovation and execution,” said Dr. Coleman. “Xilio’s shared commitment
8-K
EX-3.1
juila
3 Apr 23
Departure of Directors or Certain Officers
4:05pm
S-3
a3cxa
9 Nov 22
Shelf registration
4:15pm
DEF 14A
qwkzli 7d15fs6
26 Apr 22
Definitive proxy
4:05pm
10-K
spg ymukdtdi2t2376e
1 Mar 22
Annual report
4:07pm
S-1/A
EX-3.1
59rrbz7 uv
18 Oct 21
IPO registration (amended)
6:04am
S-1
EX-10.10
96u9hsbmo83bnvheuj
1 Oct 21
IPO registration
4:49pm
S-1
EX-3.1
nrr3neg ih
1 Oct 21
IPO registration
4:49pm
S-1
EX-10.12
w4bgx rkk
1 Oct 21
IPO registration
4:49pm
S-1
EX-10.9
8kobp2r
1 Oct 21
IPO registration
4:49pm
DRS
EX-10.11
mcwwif6gu47v
24 May 21
Draft registration statement
12:00am
DRS
EX-10.9
2c9a5o dic
24 May 21
Draft registration statement
12:00am
DRS
EX-3.1
kee2y7x dhu
24 May 21
Draft registration statement
12:00am
- Prev
- 1
- Next